Ekaterina Balaian, MD

* Clinician Scientist at the University Hospital Dresden with special interest in Myelodysplastic Syndromes
* Big fan of shared-decision making

[Ekaterina Balaian, MD @BalaianEn]

Join us for the 5th #Metabolism-based #Cancer Therapy Symposium #MbCT
Nov 18, 2025 | 12:15–17:00 CET | Online

Explore cutting-edge topics:
🧬 Cancer metabolism
🥦 Diet & microbiome in therapy
🧫 Immuno-metabolism
🎤 Anniversary keynote – An Oncologist’s Story

Registration free!

[Ekaterina Balaian, MD @BalaianEn]

I really like the idea of combining art and medicine. Emotional state might have a much bigger impact on recovery than we often realize. Thanks, #ISTH2026, for the inspiration to involve patients - and ourselves - in the healing process through the art.

[Ekaterina Balaian, MD @BalaianEn]

Heading to #ISTH2026 ! As first time visiting the hemostaseological conference, I wonder if the feeling will be different as by hematological ones. Anyway, sure to get new inspiring insights! 🇨🇵

[Metabolites MDPI @MetabolitesMDPI]

🌟Call for Papers🌟

📚 #Metabolic Insights and Therapeutic Strategies in #Hematologic Disorders

👨‍🔬Guest Editor: Dr. Ekaterina Balaian
🔗More Info: https://t.co/TNbFDkFg9d
⏰Submission Deadline: 31 July 2026

[Ekaterina Balaian, MD @BalaianEn]

As a visualist, I'm pleased to invite you to check my poster 4861 on a novel VWF mutation with unique clinical traits — and lots of strange platelet pics included! 🩸🧬
#ASH25 #hematology #vWD

[Ekaterina Balaian, MD @BalaianEn]

Love these guys ^_^
#ASH25 #ASHScavengerHunt

[Ekaterina Balaian, MD @BalaianEn]

My main takeaway from the #MDSsm clinical session at #ASH25:
The frustration over negative trials like VERONA (and others) shouldn’t just push us to rush new drugs to the clinic — we need to pause and rethink our study designs and endpoints. #ASHScavengerHunt

[Ekaterina Balaian, MD @BalaianEn]

I always believed baby wraps are the most physiological way of transporting children, now it may even save lives...

[NEJM @NEJM]

In a double-blind, randomized, placebo-controlled trial conducted in Uganda, the use of permethrin-treated baby wraps significantly reduced the incidence of clinical malaria among young children. Full trial results: https://t.co/tRs10wBoSF

[Maria Sirenko @MariaSirenko]

Excited for the start of the #VEXAS workshop @nyugrossman!

[Ekaterina Balaian, MD @BalaianEn]

The Annual DACH-MDS Meeting is always a highlight!
Honored to present our #metabolomics in #MDS data & join inspiring discussions. Excited to continue at #DGHO25!
Great to meet many colleagues — let’s stay connected!
@dgho_eV @tudresden_de

[Ekaterina Balaian, MD @BalaianEn]

@isth I would LOVE to get one, as getting visa is becoming more and more difficult... 🫣

[Ekaterina Balaian, MD @BalaianEn]

...the courage of the colleagues and by the solidarity in #Europe, providing high quality treatment even during the war.
"We are strong together" - so true. Let's pray together to stop the war.

[Ekaterina Balaian, MD @BalaianEn]

I'm deeply thankful to @EHA_Hematology for organizing session about the medical care in the #Ukraine️ during the war at #EHA2025. I'm emotionally exhausted, I'm almost crying hearing the talks from the ukranian doctors, but we need these discussions and I'm deeply impressed...

[Ekaterina Balaian, MD @BalaianEn]

Found Mr Nobel at #EHA2025 - let's check whether he will help to find the way to his birth place at #EHA2026 :) @EHA_Hematology

[David Steensma, MD @DavidSteensma]

So far, every single abstract I’ve listened to at #EHA25 reporting a clinical trial has claimed the study drug was “well tolerated” - despite patients discontinuing therapy due to AEs.

One speaker said “well tolerated” >10 times.

It’s meaningless.
Let data speak for itself.

[Ekaterina Balaian, MD @BalaianEn]

So pleased to see the important results of the #HAMLET study presented by Johannes Schetelig at #EHA25, providing more security for #MDS and #AML patients, when the perfect donor is missing... @tudresden_de @EHA_Hematology

[Goutham Sunny @medoncodoc]

🧪 New in Br J Haematol (2025):

🚫 Routine screening for MGUS is contraindicated!

❌ No benefit
😟 Same psychological distress as cancer
🔬 High false positives from κ/λ ratio
💉 Invasive tests done without prior non-invasive checks
📉 No improvement in outcomes from early detection
🧘‍♂️ Most MGUS patients never progress to MM

💡“Primum non nocere” – First, do no harm. @AaronGoodman33

#mmsm
https://t.co/bEWF3bYPMz

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

Honoring two giants in #MDSsm at the #MDSF25 @MDSFoundation biennial meeting in Rotterdam with life achievement awards to Dr John Bennett (who just turned 91) & Dr Peter Greenberg for their life long immense contributions to the field. We truly stand on the shoulders of giants!

[Ekaterina Balaian, MD @BalaianEn]

The mystery of #microbiome starts to be clearer.. Wonderful talk by @dstarczynowski at #MDS25 about mechanisms linking gut microbiome, #aging, #CHIP and #MDS - super inspiring, and Nature paper definitively worthy reading!
@MDSFoundation at #Rotterdam

[Shahram Kordasti @KordastiL]

In past 2 days, we had our annual #i4MDS meeting in The Hague. Great discussions with colleagues about the role of the immune system in MDS and novel findings. Three years ago, when we founded this group, I never expected this level of progress and collaboration. Truly delighted.